What Conditions does YERVOY Treat?

  • metastatic malignant melanoma
  • added therapy to improve treatment of melanoma
  • cancer or malignancy
  • renal cell carcinoma
  • microsatellite instability-high colorectal cancer
  • liver cell carcinoma
  • PD-L1 positive, EGFR-negative, ALK-negative metastatic non-small cell lung cancer
  • EGFR negative, ALK negative, non-small cell lung cancer
  • malignant pleural mesothelioma
Drug Survey

Are you currently using ipilimumab intravenous?

This survey is being conducted by the WebMD marketing sciences department.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.